Abraxane 100 MG Injection

RxCUI: 583218
RxNorm name: Abraxane 100 MG Injection
Display name: Abraxane 100 MG Injection
Full name: Abraxane 100 MG Injection
Term type: SY
Status: DailyMed mapping
Updated: 2026-06-04 23:38:50

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
ABRAXANE	PACLITAXEL	Abraxis BioScience, LLC	24d10449-2936-4cd3-b7db-a7683db721e4	2022-10-31	Boxed warning, Warnings, Adverse reactions	Exact identifier rxcui: 583218

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set ID	RxNorm mappings	Terms	SPL version	Label	Effective
24d10449-2936-4cd3-b7db-a7683db721e4	Abraxane 100 MG Injection [PSN] · paclitaxel 100 MG Injection [Abraxane] [SBD] · Abraxane 100 MG Injection [SY]	3	37	These highlights do not include all the information needed to use ABRAXANE safely and effectively. See full prescribing information for ABRAXANE. ABRAXANE ® for Injectable Suspension (paclitaxel protein-bound particles for injectable suspension) (albumin-bound), for intravenous use Initial U.S. Approval: 2005	20221031